Cargando…

Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review

Problematic opioid use, constituted by a myriad of conditions ranging from misuse to use disorders, has continued to receive an increasing amount of attention in recent years resulting from the high use of opioids in the United States coinciding with morbidity and mortality. Deaths from drug overdos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindley, Bryn, Cox, Nicholas, Cochran, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649304/
https://www.ncbi.nlm.nih.gov/pubmed/31410349
http://dx.doi.org/10.2147/IPRP.S185663
_version_ 1783438017009025024
author Lindley, Bryn
Cox, Nicholas
Cochran, Gerald
author_facet Lindley, Bryn
Cox, Nicholas
Cochran, Gerald
author_sort Lindley, Bryn
collection PubMed
description Problematic opioid use, constituted by a myriad of conditions ranging from misuse to use disorders, has continued to receive an increasing amount of attention in recent years resulting from the high use of opioids in the United States coinciding with morbidity and mortality. Deaths from drug overdoses increased by over 11% between 2014 and 2015, which supports the need for identification of problematic opioid use in additional health care settings. One of these settings is community pharmacy. The community pharmacy is a unique health service setting to identify and potentially intervene with patients at risk of or exhibit problematic opioid use. Problematic opioid use can be identified using one of the various screening tools in conjunction with evaluating prescription drug monitoring systems. A total of 12 tools were identified that could be employed in community pharmacy settings for identifying problematic opioid use. This review highlights these tools and strategies for use that can be utilized in the community pharmacy, which should be adapted to individual pharmacy settings and local needs. Future research should assess pharmacy personnel’s knowledge and perceptions of problematic opioid use and associated screening tools and interventions, which tools can be most effectively used in a community pharmacy, workflow needs to implement problematic opioid use screenings, and the impact of pharmacist engagement in problematic opioid use screening on patient clinical outcomes.
format Online
Article
Text
id pubmed-6649304
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66493042019-08-13 Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review Lindley, Bryn Cox, Nicholas Cochran, Gerald Integr Pharm Res Pract Review Problematic opioid use, constituted by a myriad of conditions ranging from misuse to use disorders, has continued to receive an increasing amount of attention in recent years resulting from the high use of opioids in the United States coinciding with morbidity and mortality. Deaths from drug overdoses increased by over 11% between 2014 and 2015, which supports the need for identification of problematic opioid use in additional health care settings. One of these settings is community pharmacy. The community pharmacy is a unique health service setting to identify and potentially intervene with patients at risk of or exhibit problematic opioid use. Problematic opioid use can be identified using one of the various screening tools in conjunction with evaluating prescription drug monitoring systems. A total of 12 tools were identified that could be employed in community pharmacy settings for identifying problematic opioid use. This review highlights these tools and strategies for use that can be utilized in the community pharmacy, which should be adapted to individual pharmacy settings and local needs. Future research should assess pharmacy personnel’s knowledge and perceptions of problematic opioid use and associated screening tools and interventions, which tools can be most effectively used in a community pharmacy, workflow needs to implement problematic opioid use screenings, and the impact of pharmacist engagement in problematic opioid use screening on patient clinical outcomes. Dove 2019-07-19 /pmc/articles/PMC6649304/ /pubmed/31410349 http://dx.doi.org/10.2147/IPRP.S185663 Text en © 2019 Lindley et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Lindley, Bryn
Cox, Nicholas
Cochran, Gerald
Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
title Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
title_full Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
title_fullStr Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
title_full_unstemmed Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
title_short Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
title_sort screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649304/
https://www.ncbi.nlm.nih.gov/pubmed/31410349
http://dx.doi.org/10.2147/IPRP.S185663
work_keys_str_mv AT lindleybryn screeningtoolsfordetectingproblematicopioiduseandpotentialapplicationtocommunitypharmacypracticeareview
AT coxnicholas screeningtoolsfordetectingproblematicopioiduseandpotentialapplicationtocommunitypharmacypracticeareview
AT cochrangerald screeningtoolsfordetectingproblematicopioiduseandpotentialapplicationtocommunitypharmacypracticeareview